ARCHIVES

Drug Marketing; Zeneca sues Eli Lilly, Claiming Misleading Promotion of Evista

This article is from The Cancer Letter archive.

Vol. 25 No. 10 | March 12, 1999

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

July 12, 1991

Golde To Step Down As Physician-in-Chief At Memorial Sloan-Kettering Next Year.

January 26, 2001

Survival Of Control Programs After NCI Money Runs Out Developing Into A Worrisome Issue

June 1, 1975

Komen Foundation Breast Cancer Awards

April 15, 1994

US Files Motion To Dismiss Fisher Suit Over Database Flags

November 3, 1995